Screening for chlamydial infection: A model program based on prevalence

Sexually Transmitted Diseases

Volumn 25, Issue 4, 1998, Pages 201-210

  Miller, William C ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COST BENEFIT ANALYSIS; DISEASE CONTROL; DISEASE TRANSMISSION; HEALTH CARE COST; LABORATORY TEST; PREVALENCE; PROBABILITY; RISK ASSESSMENT; SCREENING; SEXUALLY TRANSMITTED DISEASE;

ADULT; CHLAMYDIA INFECTIONS; FEMALE; HUMANS; MASS SCREENING; PATIENT SELECTION; PREVALENCE; PROGRAM EVALUATION; QUALITY CONTROL; RISK ASSESSMENT;

EID: 0031948722     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-199804000-00005     Document Type: Article

References (32)

1. CDC. Recommendations for prevention and management of Chlamydia trachomatis infections, 1993. Morb Mortal Wkly Rep 1993; 42(RR-12):1-39.
2. Institute of Medicine, Committee on Prevention and Control of Sexually Transmitted Diseases. In: Eng TR, Butler WT, eds. The hidden epidemic: Confronting sexually transmitted diseases. Washington, DC: National Academy Press, 1997.
3. Cates W, Wasserheit JN. Genital chlamydial infections: Epidemiology and reproductive sequelae. Am J Obstet Gynecol 1991;164: 1771-1781.
4. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study. AIDS 1993; 7:95-102.
5. Brunham RC, Paavonen J, Stevens CE, et al. Mucopurulent cervicitis-The ignored counterpart in women of urethritis in men. N Engl J Med 1984; 311:1-6.
6. McCormack WM, Alpert S, McComb DE, Nichols RL, Semine DZ, Zinner SH. Fifteen month follow-up study of women infected with Chlamydia trachomatis. N Engl J Med 1979; 300:123-125.
7. Handsfield HH, Jasman LL, Roberts PL, Hanson VW, Kothenbeutel RL, Stamm WE. Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics. JAMA 1986; 255:1730-1734.
8. Addis DG, Vaughn ML, Ludka D, Pfister J, Davis JP. Decreased prevalence of Chlamydia trachomatis infection associated with a selective screening program in family planning clinics in Wisconsin. Sex Transm Dis 1993; 20:28-34.
9. Stergachis A, Scholes D, Heidrich FE, Sherer DM, Holmes KK, Stamm WE. Selective screening for Chlamydia trachomatis infection in a primary care population of women. Am J Epidemiol 1993; 138:143-153.
10. Weinstock HS, Bolan GA, Kohn R, Balladares C, Back A, Oliva G. Chlamydia trachomatis infection in women: A need for universal screening in high prevalence populations? Am J Epidemiol 1992; 135:41-47.
11. Sellors JW, Pickard L, Gafni A, et al. Effectiveness and efficiency of selective vs universal screening for chlamydial infection in sexually active young women. Arch Intern Med 1992; 152:1837-1844.
12. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996; 334:1362-1366.
13. Alary M, Joly JR, Moutquin J-M, Labrecque M. Strategy for screening pregnant women for chlamydial infection in a low prevalence area. Obstet Gynecol 1993; 82:399-404.
14. Hills SD, et al. New opportunities for chlamydia prevention: Applications of science to public health practice. Sex Transm Dis 1995;22:197-202.
15. Cates W, Jr. A risk assessment tool for integrated reproductive health services. Int Fam Planning Persp 1997; 23:36-38.
16. Mosure DJ, Berman S, Fine D, Delisle S, Cates W, Jr., Boring JR, III. Genital chlamydial infections in sexually active female adolescents: Do we really need to screen everyone? J Adolesc Health 1997; 20:6-13.
17. Mertz KJ, Levine WC, Mosure DJ, Berman SM, Dorian KJ. Trends in the prevalence of chlamydial infections: The impact of community-wide testing. Sex Transm Dis 1997; 24:169-175.
18. Britton TF, DeLisle S, Fine K. STDs and family planning clinics: a regional program for chlamydia control that works. Am J Gynecol Health 1992; 6:80-87.
19. Nettleman MD, Jones RB. Proportional payment for pelvic inflammatory disease: Who should pay for chlamydial screening? Sex Transm Dis 1989; 16:36-40.
20. Trachtenberg Al, Washington AE, Halldorson S. A cost-based decision analysis for chlamydia screening in California family planning clinics. Obstet Gynecol 1988; 71:101-108.
21. Genc M, Mardh P-A. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med 1996; 124:1-7.
22. Buhaug H, Skjeldestad FE, Backe B, Dalen A. Cost effectiveness of testing for chlamydial infections in asymptomatic women. Med Care 1989; 27:833-841.
23. Phillips RS, Aronson MD, Taylor WC, Safran C. Should tests for Chlamydia trachomatis cervical infection be done during routine gynecologic visits? An analysis of the costs of alternative strategies. Ann Intern Med 1987; 107:188-194.
24. Humphreys JT, Henneberry JF, Rickard RS, Beebe JL. Cost-benefit analysis of selective screening criteria for Chlamydia trachomatis infection in women attending Colorado family planning clinics. Sex Transm Dis 1992; 19:47-53.
25. Marrazzo JM, Celum CL, Hillis SD, Fine D, DeLisle S, Handsfield HH. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women: Implications for a national chlamydia control strategy. Sex Transm Dis 1997; 24:131-141.
26. Orr DP. Urine-based diagnosis of sexually transmitted infections using amplified DNA techniques: A shift in paradigms? J Adolesc Health 1997; 20:3-5.
27. Chernesky MA, Jang D, Lee H, et al. Diagnosis of Chlamydia trachomatis infections in men and women by testing first-void urine by ligase chain reaction. J Clin Microbiol 1994: 32:2682-2685.
28. Lee HH, Chernesky MA, Schachter J, et al. Diagnosis of Chlamydia trachomati genitourinary infection in women by ligase chain reaction assay of urine. Lancet 1995; 345:213-216.
29. Schacter J, Stamm WE, Quinn TC, Andrews WW, Burczak JD, Lee HH. Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix. J Clin Microbiol 1994; 32:2540-2543.
30. Sox HC Jr, Blatt MA, Higgins MC, Marton Kl. Medical Decision Making. Boston, MA: Butterworth-Heinemann; 1988.
31. Stamm WE. Toward control of sexually transmitted chlamydial infections. Ann Intern Med 1993; 432-434.
32. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine. 2nd ed. Boston, MA: Little, Brown and Company, 1991.